Stanford scientists have developed a novel hydrogel for long-term drug delivery of an Activator Protein 1 (AP-1) inhibitor for the prevention of post-surgical abdominal adhesion.
Stanford researchers have developed a library of polymeric hydrogel formulations to prevent and/or reduce biofouling on implanted sensors and medical devices.